Anthos Investigative Site 1034 — Roy, Utah

Anthos Investigative Site 1034 is a clinical research site located in Roy, Utah, United States 84067.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Anthos Investigative Site 1034 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Atrial Fibrillation (AF).

Sponsors: Anthos Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Roy

Browse all research sites in Utah · View every site in Roy

• GSK Investigational Site
• Research Site
• Wee Care Pediatrics-Roy ( Site 0053)
• Wee Care Pediatrics
• AMR Clinical
• Ogden Clinic Grandview
• Ogden Clinic - Grandview - CCT - PPDS
• Ogden Clinic
• Avacare (CCT) - Ogden Clinic - Grand View
• 117 Wee Care(Roy) 5991 South 3500 West, Suite 100
• 342 - Ogden Clinical, Grand View/CCT Research
• Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Anthos Investigative Site 1034?

Anthos Investigative Site 1034 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Anthos Investigative Site 1034 conducted?

Anthos Investigative Site 1034 has 1 clinical trials on record, with 1 currently active. Their work covers Atrial Fibrillation (AF).

Is Anthos Investigative Site 1034 accredited by Crixeo Clinical Trials?

Anthos Investigative Site 1034 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Anthos Investigative Site 1034?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.